TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH;Astellas Pharma Inc.
发明人:
申请号：
EP19210903.1
公开号：
EP3666796A1
申请日:
2013.05.06
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
